SMPD1 rs121908251: What Your Carrier Status Means
The genetic variant rs121908251 is a single nucleotide polymorphism in the SMPD1 gene that leads to a leucine-to-proline change (p.Leu304Pro, historically referred to as L302P). Carrying one copy of this variant indicates carrier status for Niemann-Pick disease type A, a severe autosomal recessive lysosomal storage condition. Being a carrier generally does not cause Niemann-Pick disease symptoms, but it has important reproductive implications.
What each genotype means
Typical enzyme activity
You have two functional copies of the SMPD1 gene at this position and do not carry the p.Leu304Pro pathogenic variant. This genotype indicates a standard baseline risk and non-carrier status for this specific Ashkenazi Jewish founder variant linked to Niemann-Pick disease type A. It does not rule out carrier status for other uncommon variants within SMPD1 or other genes.
Carried by more than 98% of individuals of Ashkenazi Jewish ancestry and greater than 99.9% of individuals across all other global populations.
Niemann-Pick carrier
You carry one copy of the p.Leu304Pro (also referenced historically as p.Leu302Pro) pathogenic variant in the SMPD1 gene. Being an autosomal recessive carrier typically causes no personal health symptoms because one copy produces functional acid sphingomyelinase enzyme. If you and your reproductive partner are both carriers of an SMPD1 pathogenic variant, there is a 25% chance in each pregnancy of having a child affected by Niemann-Pick disease.
Carried by approximately 1 in 90 individuals of Ashkenazi Jewish ancestry, but extremely rare (well under 1 in 1,000) in most other ancestral populations.
Severe enzyme deficiency
Two copies of the p.Leu304Pro variant in the SMPD1 gene cause a severe deficiency of acid sphingomyelinase enzyme activity. In medical literature, biallelic inheritance of this pathogenic variant is classically diagnostic of Niemann-Pick disease type A (infantile neurodegenerative acid sphingomyelinase deficiency). Individuals with this genotype experience progressive, severe neurodegenerative decline and visceral involvement in infancy.
Extremely rare worldwide, estimated at approximately 1 in 32,000 to 1 in 40,000 in Ashkenazi Jewish populations and virtually absent in other backgrounds.
What Is rs121908251 and Where Is It Located?
The variant rs121908251 represents a missense change located in the SMPD1 gene on chromosome 11. At the molecular level, this substitution alters a specific nucleotide in the coding sequence (often referenced as c.911T>C in current transcripts or c.905T>C in historical literature), resulting in the amino acid substitution p.Leu304Pro (historically labeled p.Leu302Pro or L302P). This alters a single building block of the resulting protein, profoundly impairing its normal shape and functionality. In genomic databases such as dbSNP and ClinVar, this allele is cataloged as a well-documented pathogenic variant associated with acid sphingomyelinase deficiency. Because it is a point mutation, individuals typically inherit either the standard wild-type nucleotide (T) or the variant nucleotide (C) from each parent.
The Biological Role of the SMPD1 Gene
The SMPD1 gene encodes acid sphingomyelinase (ASM), a critical hydrolytic enzyme found within lysosomes—the recycling centers of the cell. Under healthy conditions, acid sphingomyelinase breaks down the complex lipid sphingomyelin into ceramide and phosphocholine. These breakdown products are essential components of cell membranes and intracellular signaling cascades. When an individual inherits two non-functioning copies of the SMPD1 gene, sphingomyelin cannot be properly broken down and progressively accumulates inside cells and tissues throughout the body, particularly affecting the spleen, liver, lungs, and central nervous system. The p.Leu304Pro alteration almost completely eliminates enzymatic activity, linking it directly to the severe cellular disruption seen in infantile acid sphingomyelinase deficiency.
Carrier Status and Associated Health Research
Niemann-Pick disease type A (NPA) is an autosomal recessive disorder, meaning an individual must inherit two pathogenic SMPD1 variants (one from each parent) to manifest the severe infantile neurological condition. An individual who has only one copy of the rs121908251 variant is classified as an asymptomatic carrier. Extensive clinical literature in resources such as MedlinePlus Genetics and GeneReviews confirms that having a single copy does not cause Niemann-Pick disease. While emerging neurological research has investigated whether single heterozygous variants in the SMPD1 gene might confer a modest susceptibility to late-onset conditions such as Parkinson's disease, the overall clinical evidence remains limited and is currently considered an area of ongoing study rather than an established diagnostic finding.
Population Frequency and Ancestry Patterns
The frequency of rs121908251 varies considerably across different ancestral backgrounds. In the general global population, the variant allele is extremely rare, often detected at negligible frequencies in large reference databases such as gnomAD. However, it represents one of the three classic founder mutations in individuals of Ashkenazi Jewish ancestry. In this population, the carrier frequency for rs121908251 is estimated at approximately 1 in 90 to 1 in 100 individuals. Together with two other founder mutations (fsP330 and R496L), it accounts for the vast majority of Niemann-Pick disease type A carrier alleles in this demographic group, which has led to its inclusion in standard preconception carrier screening panels.
Understanding and Using This Genetic Information
Discovering an rs121908251 variant primarily provides valuable insight for family planning rather than personal day-to-day medical management. Because autosomal recessive conditions require two mutated alleles to manifest, a child is only at risk of inheriting Niemann-Pick disease type A if both biological parents carry a pathogenic variant in the SMPD1 gene. This genetic finding is strictly informative and is not a medical diagnosis of active disease. Anyone who learns they are a carrier should consider speaking with a board-certified genetic counselor or their healthcare provider. A genetics professional can facilitate carrier screening for a reproductive partner and discuss available reproductive options and family counseling.
How common is this variant?
The rs121908251 variant is very rare in most global populations but has an elevated carrier frequency of approximately 1 in 90 individuals of Ashkenazi Jewish descent due to founder effects.
Frequently asked questions
Does having the CT genotype mean I have Niemann-Pick disease?
No, having one copy of the variant (CT genotype) means you are an asymptomatic carrier. Niemann-Pick disease type A is an autosomal recessive condition, which requires inheriting two non-working gene copies to develop the illness.
What is the difference between Niemann-Pick type A and type B?
Both type A and type B are caused by mutations in the SMPD1 gene that impair the acid sphingomyelinase enzyme. Type A involves complete or near-complete loss of enzyme function leading to early-onset neurodegeneration, whereas type B retains partial enzyme activity and primarily causes visceral symptoms without severe early infant nervous system decline.
Could my children inherit Niemann-Pick disease if I am a carrier?
A child can only develop Niemann-Pick disease type A if both biological parents are carriers of an SMPD1 pathogenic mutation. If both parents are carriers, there is a 25% chance with each pregnancy that the child will inherit both mutated copies and develop the disease.
Why is this mutation often referred to as L302P instead of Leu304Pro?
Older scientific literature numbered amino acids based on mature protein models that omitted certain signal peptides, designating this change as L302P. Modern standardized genomic transcripts (HGVS nomenclature) number the sequence from the initial methionine, designating it p.Leu304Pro.
Sources & further reading
Educational information only, last refreshed 9/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908251?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29